+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Impact of prestroke oral anticoagulation on severity and outcome of ischemic and hemorrhagic stroke in patients with atrial fibrillation



Impact of prestroke oral anticoagulation on severity and outcome of ischemic and hemorrhagic stroke in patients with atrial fibrillation



Cerebrovascular Diseases 29(5): 476-483



Stroke prevention with oral anticoagulation is effective in patients with atrial fibrillation. An additional beneficial effect of oral anticoagulation prior to the event on stroke severity and prognosis was suggested in ischemic strokes. We tested whether this benefit is preserved after inclusion of hemorrhagic strokes and adjustment for prestroke living conditions. Data were used from a prospective hospital-based intervention trial evaluating quality of care and outcome in ten district hospitals. All ischemic and hemorrhagic stroke patients with atrial fibrillation were included. We analyzed separate multivariable regression models to identify factors associated with prescription of oral anticoagulation before stroke and to investigate the independent effect of anticoagulation on admission stroke severity, 3-month mortality and functional outcome. The analysis comprised 804 (718 ischemic, 86 hemorrhagic) stroke patients admitted between July 2003 and March 2005. Males, patients aged 65-84, living independently, with diabetes, previous cerebrovascular event or additional high cardioembolic risks were more likely to receive oral anticoagulation before admission. Admission international normalized ratio (INR) between 2 and 3 (OR 0.35, 95% CI: 0.17-0.71) or higher (OR 0.32, 95% CI: 0.11-0.92) was associated with less severe strokes (including hemorrhagic strokes) compared with INR <2. Anticoagulation was associated with decreased risk of death and poor functional outcome (modified Rankin Scale >3) at 3 months (OR 0.54, 95% CI: 0.36-0.84, and OR 0.70, 95% CI: 0.47-1.06). After adjustment for stroke severity, anticoagulation had no additional effect on mortality and functional outcome. The beneficial effect of prestroke anticoagulation on stroke outcome related to the reduced stroke severity is not offset by adverse effects in hemorrhagic stokes.

(PDF emailed within 0-6 h: $19.90)

Accession: 053722490

Download citation: RISBibTeXText

PMID: 20299787

DOI: 10.1159/000297963


Related references

Prestroke anticoagulation and paroxysmal type are correlated with favorable outcome in ischemic stroke patients with atrial fibrillation. Journal of Stroke and Cerebrovascular Diseases 21(1): 11-17, 2012

Adequacy of preadmission oral anticoagulation with vitamin K antagonists and ischemic stroke severity and outcome in patients with atrial fibrillation. Journal of Thrombosis and Thrombolysis 41(2): 336-342, 2016

The impact of anticoagulation intensity on severity of stroke in atrial fibrillation The anticoagulation and risk factors in atrial fibrillation study. Circulation. 106(19 Supplement): Ii-577-Ii-578, Ember 5, 2002

Ischemic stroke in patients with atrial fibrillation receiving oral anticoagulation. Journal of the Neurological Sciences 334(1-2): 139-142, 2014

Impact of anticoagulation on poststroke mortality in ischemic stroke patients with atrial fibrillation. Stroke 38(7): E61; Author Reply E62, 2007

Anticoagulation influences long-term outcome in patients with nonvalvular atrial fibrillation and severe ischemic stroke. American Journal of Geriatric PharmacoTherapy 2(4): 265-273, 2005

The Dose of Direct Oral Anticoagulants and Stroke Severity in Patients with Acute Ischemic Stroke and Nonvalvular Atrial Fibrillation. Journal of Stroke and Cerebrovascular Diseases 27(6): 1490-1496, 2018

Impact of CHADS(2) Score on Neurological Severity and Long-Term Outcome in Atrial Fibrillation-Related Ischemic Stroke. Journal of Clinical Neurology 8(4): 251-258, 2013

Oral Anticoagulation and Prognosis of Patients with Atrial Fibrillation After Ischemic Stroke: A Real-world Data Analysis. European Cardiology 12(2): 95, 2018

Prestroke treatment with beta-blockers for hypertension is not associated with severity and poor outcome in patients with ischemic stroke: data from a national stroke registry. Journal of Hypertension 35(4): 870-876, 2016

Prestroke CHA 2 DS 2 -VASc Score and Severity of Acute Stroke in Patients with Atrial Fibrillation: Findings from RAF Study. Journal of Stroke and Cerebrovascular Diseases 26(6): 1363-1368, 2017

Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. Circulation 127(2): 224-232, 2013

Adequate Adherence to Direct Oral Anticoagulant is Associated with Reduced Ischemic Stroke Severity in Patients with Atrial Fibrillation. Journal of Stroke and Cerebrovascular Diseases 2018, 2018

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. New England Journal of Medicine 349(11): 1019-1026, 2003

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. Acc Current Journal Review 13(1): 13-14, 2004